Oncology Institute, Inc.
TOIIWNasdaq
$0.07
↑ +0.1%Jul 17 close · end-of-day
Price
1Y↓ -21.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$7.1M
Enterprise Value
$85.7M
P/E
—
P/S
0.0
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
-362.1%
Dividend Yield
—
Revenue (TTM)
$545.8M
Net Income (TTM)
$60.6B
Free Cash Flow (TTM)
-$25.7M
Gross Margin
—
Operating Margin
-6.0%
Net Margin
11107.9%
ROE
-372263.4%
ROIC
-41.4%
Debt / Equity
-4.8
Net Cash
-$78.6M
Return 1Y
-26.5%
Earnings
TOIIW Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$147.4M↑ +41.2%
Diluted EPS-$0.02↓ -90.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $187.5M | $203.0M | $252.5M | $324.2M | $393.4M | $502.7M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$8.2M | -$45.9M | -$82.0M | -$77.0M | -$60.1M | -$36.1M |
| Net income | -$14.3M | -$10.9M | $152,000.00 | -$83.1M | $64.7B | $60.6B |
| Diluted EPS | -$0.24 | -$0.16 | -$0.21 | -$0.92 | -$0.71 | -$0.54 |
| Operating cash flow | $508,000.00 | -$32.7M | -$61.8M | -$36.3M | -$26.5M | -$24.6M |
| Free cash flow | -$686,000.00 | -$35.5M | -$67.3M | -$40.9M | -$30.3M | -$27.8M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -4.4% | -22.6% | -32.5% | -23.8% | -15.3% | -7.2% |
| Net margin | -7.6% | -5.4% | 0.1% | -25.6% | 16436.5% | 12055.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $98.6M | $99.9M | $100.3M | $104.4M | $119.8M | $136.6M | $142.0M | $147.4M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$16.4M | -$13.9M | -$11.9M | -$9.9M | -$11.2M | -$8.1M | -$6.9M | -$6.5M |
| Net income | -$15.5M | -$16.1M | $64.7B | -$19.6M | -$17.0M | -$16.5M | $60.7B | -$2.5M |
| Diluted EPS | -$0.17 | -$0.18 | -$0.14 | -$0.21 | -$0.15 | -$0.14 | -$0.04 | -$0.02 |
| Operating cash flow | -$15.7M | $819,000.00 | $4.0M | -$5.0M | -$10.2M | -$12.6M | $3.2M | -$2.2M |
| Free cash flow | -$17.5M | $417,000.00 | $2.2M | -$5.3M | -$11.4M | -$13.2M | $2.2M | -$3.3M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -16.6% | -13.9% | -11.9% | -9.5% | -9.4% | -5.9% | -4.9% | -4.4% |
| Net margin | -15.7% | -16.1% | 64542.2% | -18.8% | -14.2% | -12.1% | 42730.6% | -1.7% |
Company news
Coming soonHeadlines for TOIIW will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.